Previous 10 | Next 10 |
Concept Submitted to National Science Foundation for Funding Grant SUWANEE, GA, April 09, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) announced today the successful filing of a patent for use of shockwaves to treat respiratory ailments ...
SUWANEE, GA, April 02, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) and NanoVibronix, Inc. have announced an exclusive worldwide license agreement for NanoVibronix’s surface acoustic wave ultrasound technology in the wound care mar...
NanoVibronix (NASDAQ: NAOV ) signed a license agreement with Sanuwave Health ( OTCQB:SNWV ) for the manufacture and delivery of its WoundShield technology. More news on: SANUWAVE Health, Inc., NanoVibronix, Inc., Healthcare stocks news, Read more ...
ELMSFORD, N.Y. , April 2, 2020 /PRNewswire/ -- NanoVibronix, Inc ., (NASDAQ: NAOV), a medical device company that produces the UroShield ® , PainShield ® and WoundShield ® , and WoundShield ® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devic...
SANUWAVE Health, Inc. (SNWV) Q4 2019 Results Conference Call March 31, 2020 09:00 AM ET Company Participants Lisa Sundstrom - Chief Financial Officer Kevin Richardson - Chairman and Chief Executive Officer Conference Call Participants Presentation Operator Ladies and ...
COVID-19 Related Business Update SUWANEE, GA, March 31, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) reported financial results for the year ended December 31, 2019 with the SEC on Monday, March 30, 2020. The Company will also host a confer...
SUWANEE, GA, March 27, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) announced today that the Company will host a conference call on Tuesday, March 31, 2020, beginning at 9AM Eastern Time to discuss the 2019 financial results, provide a business upd...
SUWANEE, GA, Feb. 20, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) – is pleased and proud to announce their participation and world-wide launch of dermaPACE® at the World Union of Wound Healing Society (WUWHS) 2020 in Abu Dhabi, UAE Mar...
SUWANEE, GA, Feb. 07, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) today announced the appointment of Dr. Tom Price to its Board of Directors. Dr. Price brings over 30 years of medical practice and knowledge to SANUWAVE. Dr. P...
Suwanee, GA - ( NewMediaWire ) - February 07, 2020 - SANUWAVE Health, Inc. (OTCQB: SNWV) today announced the appointment of Dr. Tom Price to its Board of Directors. Dr. Price brings over 30 years of medical practice and knowledge to SANUWAVE. Dr. Price’s e...
News, Short Squeeze, Breakout and More Instantly...
SANUWAVE is pleased to announce preliminary revenues of $7.0 million to $7.2 million for the second quarter ended June 30, 2024. This represents the highest quarterly revenues in company history. Q1 2024 revenue increased between 50% and 54% compared to Q2 2023. UltraMist revenues for Q2 2024...
Company to Pursue Alternate Plans for Capital Structure Improvement Including a Proposed Reverse Stock Split and a Note and Warrant Exchange Independent of a Merger Transaction EDEN PRAIRIE, MN - ( NewMediaWire ) - June 26, 2024 - SANUWAVE Health, Inc. (the “Company”...
SANUWAVE pays off $6.3 million Celularity note and interest for $2.075 million SEPA merger outside date to be extended to June 30, 2024 Combined entity has applied to list on Cboe BZX Exchange, Inc. EDEN PRAIRIE, MN - ( NewMediaWire ) - June 04, 2024 - SANUWAVE...